Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include Sepsis Diagnosis and Treatment, Hemodynamic Monitoring and Therapy, SARS-CoV-2 and COVID-19 Research, and Trauma, Hemostasis, Coagulopathy, Resuscitation.
Interpretability of an FDA-authorized AI/ML sepsis diagnostic tool improved by SHAP values.
Genomic Surveillance of Human Metapneumovirus in the United States, 2010–2025
Plasma chondroitin sulfate predicts the effectiveness of fluid resuscitation strategies in patients with sepsis.
The immunology of sepsis: translating new insights into clinical practice
Clinical validation of an AI-based blood testing device for diagnosis and prognosis of acute infection and sepsis
The Sepsis ImmunoScore Predicts Sepsis, Mortality, and Deterioration Better than Clinical Scores and Widely Available Biomarkers
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults
FDA-Authorized AI/ML Tool for Sepsis Prediction: Development and Validation
FDA-Authorized AI/ML Tool for Sepsis Prediction: Development and Validation
Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity—IVY Network, 26 Hospitals, 18 October 2023–9 March 2024
Temporal Transitions of the Hyperinflammatory and Hypoinflammatory Phenotypes in Critical Illness
Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis
Identification of a hyperinflammatory sepsis phenotype using protein biomarker and clinical data in the ProCESS randomized trial
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study
Effectiveness of Original Monovalent and Bivalent COVID‐19 Vaccines Against COVID‐19‐Associated Hospitalization and Severe In‐Hospital Outcomes Among Adults in the United States, September 2022–August 2023
Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses — IVY Network, September 1, 2022–March 30, 2023
Association Between Neuromuscular Blocking Agents and Outcomes of Emergency Tracheal Intubation: A Secondary Analysis of Randomized Trials
Video versus Direct Laryngoscopy for Tracheal Intubation of Critically Ill Adults
The future of intensive care: the study of the microcirculation will help to guide our therapies
Vaccine Effectiveness Against Influenza A–Associated Hospitalization, Organ Failure, and Death: United States, 2022–2023
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021–August 2022
Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report—IVY Network, February 1–August 31, 2022
Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
Redefining critical illness
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022
Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults — United States, August–December 2021
Patient Factors Associated With Appendectomy Within 30 Days of Initiating Antibiotic Treatment for Appendicitis
Analysis of Outcomes Associated With Outpatient Management of Nonoperatively Treated Patients With Appendicitis